Prelude Capital Management, LLC Repligen Corp Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Repligen Corp stock. As of the latest transaction made, Prelude Capital Management, LLC holds 1,790 shares of RGEN stock, worth $223,266. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,790
Previous 1,790 -0.0%
Holding current value
$223,266
Previous $266,000 -0.0%
% of portfolio
0.02%
Previous 0.01%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$119.79 - $167.35 $214,424 - $299,556
1,790 New
1,790 $266,000
Q4 2023

Feb 14, 2024
BUY
$114.17 - $185.35 $447,546 - $726,572
3,920 New
3,920 $704,000
Q1 2023

May 15, 2023
BUY
$154.26 - $198.1 $2,313 - $2,971
15 Added 0.64%
2,365 $398,000
Q4 2022

Feb 14, 2023
BUY
$162.42 - $220.56 $381,686 - $518,316
2,350 New
2,350 $397,000
Q1 2022

May 16, 2022
SELL
$161.19 - $257.96 $415,709 - $665,278
-2,579 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$247.59 - $304.47 $72,543 - $89,209
-293 Reduced 10.2%
2,579 $683,000
Q3 2021

Nov 15, 2021
SELL
$194.77 - $324.21 $11,686 - $19,452
-60 Reduced 2.05%
2,872 $830,000
Q2 2021

Aug 16, 2021
BUY
$165.87 - $220.95 $486,330 - $647,825
2,932 New
2,932 $585,000
Q1 2021

May 17, 2021
SELL
$180.37 - $226.26 $209,589 - $262,914
-1,162 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$148.08 - $206.57 $172,068 - $240,034
1,162 New
1,162 $223,000
Q4 2019

Feb 14, 2020
SELL
$73.84 - $93.08 $11,962 - $15,078
-162 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$76.65 - $95.51 $843 - $1,050
-11 Reduced 6.36%
162 $12,000
Q2 2019

Aug 14, 2019
BUY
$54.2 - $85.95 $6,937 - $11,001
128 Added 284.44%
173 $15,000
Q1 2019

May 15, 2019
SELL
$49.45 - $62.8 $3,164 - $4,019
-64 Reduced 58.72%
45 $3,000
Q4 2018

Feb 14, 2019
BUY
$48.26 - $68.88 $5,260 - $7,507
109 New
109 $6,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email